The lack of treatment options for COVID-19 patients, potential promise in repurposing drugs, and controversy surrounding the anti-malarial drug hydroxychloroquine have created a storm of questions about the drug’s efficacy that the National Institute of Allergy and Infectious Diseases (NIAID) is ready to answer. To do that, the organization is sponsoring a large randomized, controlled clinical trial to determine whether hydroxychloroquine, given in combination with the antibiotic azithromycin, can prevent hospitalization and death due to COVID-19.
Image: Hydroxychloroquine freebase molecule – https://en.wikipedia.org/wiki/Hydroxychloroquine
{iframe}https://www.genengnews.com/news/nih-launches-clinical-trial-to-study-hydroxychloroquine-efficacy-in-covid-19/?utm_medium=newsletter&utm_source=GEN+Daily+News+Highlights&utm_content=01&utm_campaign=GEN+Daily+News+Highlights_20200515&oly_enc_id=1673D8247356B7U{/iframe}